Skip to content
DataLookout
Menu

NCT07568132

Efferon LPS Hemoadsorption in in Patients With Thermal Burns

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Start date changed from estimate of May 15, 2026 to Oct 21, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 2 of 7 entries
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Need for vasopressor support
Timeframe: 1-28 days

Secondary (7)

Horowitz oxygenation index
Renal replacement therapy (RRT) free days
28 and 60 days mortality
Length of stay in the intensive care unit
Duration of hospitalization
Show 2 moreShow less
Frequency of septic complications
Frequency of surgical interventions

Arms and interventions

Baseline therapyNo intervention

Patients receiving standard treatment for the treatment of thermal burns without the use of hemoadsorption methods, but who are prescribed continuous renal replacement therapy (CRRT) for renal and non-renal indications.

Baseline therapy + Efferon LPSExperimental

Patients receiving standard therapy for the treatment of thermal burns, along with Efferon LPS hemoadsorption procedures in combination with continuous renal replacement therapy (CRRT).

Devices: Efferon LPS

Sites

1 site in 1 country

  • N.V. Sklifosovsky Research Institute for Emergency MedicineMoscow, Russia